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Abstract
To gain insight into the molecular epidemiology and possible mechanisms of genetic variation of porcine reproductive and
respiratory syndrome (PRRS) in Yunnan Province of China, the ORF5 gene of 32 PRRSV isolates from clinical samples
collected from 2007 to 2009 were sequenced and analyzed. Nucleotide and amino acid analyses were carried out on 32
isolates and representative strains of the North American genotype, European genotype and two representative Chinese
isolates. Results revealed that these isolates share 86.9–99.0% nucleotide and 87.5–98.0% amino acid identity with VR-2332
the prototypical North American PRRSV, 61.7–62.9% and 54.3–57.8% with Lelystad virus (LV) the representative strain of
European genotype, 91.2–95.4% and 90.0–94.5% with CH-1a that was isolated in mainland China in 1996, 88.1–99.3% and
85.5–99.0% with JX-A1 the representative strain of High pathogenic PRRSV in China, and 86.2–99.8% and 85.5–100.0%
between isolated strains of different years, respectively. Phylogenetic analysis revealed that all 32 PRRSV isolates belonged
to the North American genotype and were further divided into two different subgenotypes. Subgenotype 1 comprised
twenty two Yunnan isolates which divided into two branches. Subgenotype 2 comprised ten isolates which closely related
to the RespPRRS vaccine and its parent strain VR-2332. The functional domains of GP5 such as the signal peptide,
ectodomain, transmembrane regions and endodomain were identified and some motifs in GP5 with known functions, such
as primary neutralizing epitope (PNE) and decoy epitope were also further analyzed. Our study shown the great genetic
diversity of PRRSV in southwest China, rendering the guide for control and prevention of this disease.
Citation: Yin G, Gao L, Shu X, Yang G, Guo S, et al. (2012) Genetic Diversity of the ORF5 Gene of Porcine Reproductive and Respiratory Syndrome Virus Isolates in
Southwest China from 2007 to 2009. PLoS ONE 7(3): e33756. doi:10.1371/journal.pone.0033756
Editor: Binu T. Velayudhan, Texas Veterinary Medical DIagnostic Laboratory-Amarillo, Texas A&M System, United States of America
Received October 8, 2011; Accepted February 16, 2012; Published March 20, 2012
Copyright:  2012 Yin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Natural Science Foundation of China (Grant No. 30860205, 31160509) and Yunnan Provincial Program for
Introducing High-level Scientists (Grant No. 2009CI125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: wenguili@yeah.net
Introduction
Porcinereproductive and respiratorysyndrome(PRRS)isthemost
economically significant disease of swine worldwide. The disease
mainly causes premature delivery, miscarriage, stillbirth, mummified
fetuses, severe pneumonia, edema and conjunctivitis in pigs. Typical
PRRS is also called ‘‘blue ear’’ disease due to a representative
symptom of the infected piglets [1]. In addition, coinfection and
secondary infection causes significantly higher mortality rate [2].
PRRS first emerged in late 1987 in the United States and three
years later in Europe. Two genotypes are recognized for Porcine
reproductive and respiratory syndrome virus (PRRSV), the North
American genotype and the European genotype, as represented by
the prototypes VR-2332 and Lelystad virus (LV), respectively [3].
In mainland China, the North American genotype was first
reported in 1996 and it has spread throughout the country with
considerable genetic variation [4].
PRRSV belongs to the family Arteriviridae in the order
Nidovirales, a family of positive-sense, single stranded linear
RNA viruses. PRRSV is an enveloped arterivirus, 50–60 nm in
size. The genome is about 15 kb in length which contains nine
ORFs. The 39 end of the genome encodes four membrane-
associated glycoproteins (GP2, GP3, GP4 and GP5, encoded by
subgenomic mRNAs 2a, 3, 4 and 5), two unglycosylated
membrane proteins (E and M, encoded by subgenomic mRNAs
2b and 6) and a nucleocapsid protein [5,6]. The 59 untranslated
region (59 UTR) includes stem loop 2 which is a key structural
element for PRRSV replication and subgenomic mRNA synthesis
[7]. A recent study revealed that a 51 amino acid polypeptide
referred to as ORF5a was encoded by an alternative ORF of the
subgenomic mRNA encoding GP5, and a similar ORF was
present as an alternative reading frame in all PRRSV subgenomic
RNA5 genes and in all other arteriviruses [8].
The GP5 protein is the primary envelope protein, a glycopro-
tein of approximately 200 amino acids with an apparent molecular
mass of 26 kDa. There are 2–4 glycosylation sites, a 31 amino acid
signal peptide and 6 antigenic determinants which induce
neutralizing antibodies included in GP5. The presence of a major
neutralization epitope in the N-terminal ectodomain implied that
GP5 is involved in receptor recognition [9].
As the main candidate protein for development of subunits
vaccine, also due to its immunological significance and polymor-
phic nature, GP5 has been the target for analysis of genetic
diversity of PRRSV [10]. In the present study, ORF5 gene of 32
PRRSV isolates from clinical samples in Yunnan (southwest
China) during the period of 2007–2009 were sequenced and
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PRRS.
Materials and Methods
1. Sample collection
A total of 810 clinical samples including lung, blood and semen
weresampled from different swineherds that experienced outbreaks
of severe reproductive failure in pregnant sows and respiratory
problems in sucking and post-weaning piglets in Yunnan Province,
southwestern China from 2007 to 2009.
Sampling procedures were approved by the Animal Care and
Use Committee of Yunnan Province, China, which does not issue a
number to any animal study. Our sampling processes were assisted
by local authorities and veterinarians. Blood was sampled in each
PRRS suspect cases, boar semen was collected with an artificial
vagina and lung samples were collected during necropsy. Pieces of
the tissues from pigs were homogenized for RNA extraction and
virus isolation, remaining samples were kept at 270uC.
2. RNA Extraction and Reverse Transcription
Total RNA was extracted from the tissue homogenates using
Qiagen RNeasy Mini kit. The extracted RNA was dissolved in
RNase-free pure water and used immediately for reverse
transcription in a final 20 ml reaction volume. Reaction mixtures
consisted of 6 ml RNA solution, 0.5 ml 10 mM Y4 reverse primer,
0.5 ml (40 U) RNAase inhibitor (Toyobo Co. Japan), 4 ml
56MMLV Buffer and 1 ml 10 mM dNTPs. Before 1 ml (100 U)
MMLV (Takara Co. Dalian, China) was added, the mix was
incubated at 70uC for 5 min and then placed on ice for 5 min.
Reverse transcription was conducted at 42uC for 1 hour, with a
final termination at 70uC for 15 min.
3. Primer design and RT-PCR
Based upon multiple sequence alignment, a set of PRRSV
primers Y3 and Y4 were designed for RT-PCR assay. The sense
primer Y3 was 59-cca tgt tgg aga aat gct tg-39 and the reverse
primer Y4 was 59-cgg ccg cga ctc acc ttt ag-39. The cycling
conditions were 95uC for 5 min, followed by 30 cycles of 94uC for
40 sec, 56uC for 40 sec, 72uC for 60 sec, and a final extension at
72u C for 10 min. This yielded a 708 bp PCR product containing
complete ORF5 gene of PRRSV.
4. Cloning, sequencing and phylogenetic analysis of PCR
products
The PCR products were purified using PCR purification kit
(TaKaRa Co. Dalian, China) and cloned into the pMD18-T vector
(TaKaRa Co. Dalian, China). The plasmid was then used to
transformE.ColiDH5a. The plasmids were extracted and the inserts
sequenced at Sangon Biological Engineering Company (Shanghai,
China). The 708 nt consensus sequences were aligned using DNA-
man (version 6.0, Lynnon Co.). Genetic distances between PRRSV
sequences were calculated with the DNAStar software (Hitachi,
version 7.1, Madison WI, USA). Phylogenetic and molecular
evolutionary genetic analyses were conducted using the neighbor-
joining method with MEGA (Version 4,Tamura, Dudley, Nei, and
Kumar 2007). A total of 29 North American genotypes and 1
European genotype were used as references in the analysis (Table 1).
5. Amino acid analysis of GP5
To get a better understanding of the genetic relationship and
evolution of PRRSV in Yunnan from 2007 to 2009, phylogenetic
analysis was carried out based on the sequences of the ORF5 gene
of Yunnan Province isolated PRRSV strains, together with some
North American genotype isolates from China and other
countries. In particular, some known functional domains of GP5
such as the signal peptide, ectodomain, transmembrane regions
and endodomain were identified, some motifs in GP5 like primary
neutralizing epitope (PNE) and decoy epitope were also analyzed
according to a previous report [11].
Results
1. RT-PCR survey of clinical samples
PRRSV was detected in 51 (10 strains in 2007, 25 strains in
2008 and 16 strains in 2009) out of 810 clinical samples by RT-
PCR, the total positive rate was 6.3% (51/810).
2. Sequence and phylogenetic analyses of ORF5
51 strains sequences were designated in order of isolation from
YN07-00 to YN09-50. A further blast-search using the public database
Table 1. Representative PRRSV Strains used in the
phylogenetic and sequence analyses.
NO. Name Area Year Accession No.
1 LV Netherlands 1993 M96262
2 VR-2332 USA 1995 U87392
3 Clone20 China:Hubei 2003 FJ899592
4 4139 USA:MN 2005 EU756000
5 RespPRRS USA 2005 AF066183
6 SCQ China:Sichuan 2006 DQ379479
7 BHA China:Guangxi 2006 EF104600
8 CC-1 China:Jilin 2006 EF153486
9 HB-3(cz) China:Hebei 2006 EU478435
10 5554 Canada:MB 2006 EU756566
11 JSyx China:Jiangsu 2006 EU939312
12 JX-A1* China:Jiangxi 2006 EF112445
13 GZZB China:Guizhou 2007 EU140611
14 JX3 China:Jiangxi 2006 EU213137
15 Hainan-2 China:Hainan 2007 EF398052
16 GDB11 China:Guangdong 2007 GU980181
17 pJX148 China:Jiangxi 2007 EF488048
18 HBAN1 China:Hubei 2008 EU371943
19 4034-2-V-2008 South Korea 2008 FJ972733
20 JN-HS China: Shandong 2008 HM016158
21 FJ07B China:Fujian 2008 GU358694
22 CQJ-1 China: Chongqing 2008 FJ919335
23 AHXS4 China:Hubei 2008 EU399857
24 JX5 China:Jiangxi 2006 EU213139
25 GZJL China: Guizhou 2009 FJ947000
26 BZHM China:Shandong 2009 GU977226
27 BB0907 China:Guangxi 2009 HQ315835
28 5112HCM Viet Nam:Ho Chi
Minh
2010 HQ700878
29 Ch-1a# China:Beijing 1996 AY032626
30 WUH1 HuBei 2007 EU187484
*JX-A1 is the representative strain of HP-PRRSV in China since 2006;
#Ch-1a is the first PRRSV isolate in mainland China in 1996.
doi:10.1371/journal.pone.0033756.t001
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9, 15, 16, 21, 22, 25, 26,27,30,32, 33, 34, 36, 41, 45, 46, 48, 49)shared
identical sequences and were removed, so that finally 32 Yunnan
strains were identified in this study. These sequences for GP5 genes of
individual isolates were deposited in GenBank (Table 2).
Further sequence analysis identified all 32 isolated strains
belonging to North American genotype. Compared with repre-
sentative strain VR-2332 for the North American genotype, LV
for the European genotype, CH-1a and JX-A1 for Chinese
isolates, nucleotide homologies ranged from 86.9–99.0%, 61.7–
62.9%, 91.2–95.4% and 88.1–99.3%, respectively, and 86.2–
99.8% between different years isolated strains (Table 3). A
phylogenetic tree was constructed using the neighbor-joining
method based on sequences of 32 isolates of PRRSV from Yunnan
Province and 29 references PRRSV sequences from China and
other countries. As shown in Figure 1, all 32 PRRSV isolates were
divided into two different subgenotypes. Subgenotype 1 comprised
twenty two Yunnan isolates which divided into two branches. One
branch include 13 strains which all the strains isolated from
Yunnan and the other include nine Yunnan isolate, along with JX-
A1 the representative strain of HP-PRRSV in China since 2006
and other related PRRSV. Subgenotype 2 comprised ten isolates
that were highly homologous to each other and closely related to
the RespPRRS vaccine and its parent strain VR-2332.
3. Amino acid analysis of the GP5
To investigate the amino acid difference among the two
subgenotype isolates, the GP5 amino acid sequences of 32 PRRSV
isolates were aligned, together with some North American
genotype isolates from China and other countries. Multiple
alignments of GP5 sequences of Chinese PRRSV isolates indicated
that all 32 isolates encode a GP5 protein of 200 amino acid
residues, but that substitutions were extensive (Fig. 2).
Pairwise comparison revealed 85.5–100.0% deduced amino acid
similaritybetweenthe32YunnanPRRSVisolatesandshared87.5–
98.0% amino acid identity with the prototypical North American
PRRSV VR-2332, 54.3–57.8% with strain LV the European type,
85.5–99.0% with JX-A1, and 90.0–94.5% with CH-1a (Table 3).
Compared with those in subgenotypes 2, Yunnan PRRSV
strains in subgenotypes 1 were found to be highly variable in the
Table 2. Information of 32 PRRSV isolated in Yunnan Province, China.
No. Isolate Isolation year
Genebank accession
No. No. Isolate Isolation year
Genebank accession
No.
1 yn07-0 2007 JF920761 17 yn08-20 2008 JF920771
2 YN-1 2007 FJ151490 18 yn08-23 2008 JF920774
3 YN-2 2007 FJ361883 19 yn08-24 2008 JF920775
4 YN-3 2007 FJ361884 20 yn08-28 2008 JF920779
5 YN-4 2007 FJ361885 21 yn08-29 2008 JF920780
6 YN-5 2007 FJ361886 22 yn08-31 2008 JF920782
7 YN-6 2007 FJ361887 23 yn09-35 2009 JF920786
8 YN-8 2007 FJ361889 24 yn09-37 2009 JF920788
9 YN-10 2008 FJ361891 25 yn09-38 2009 JF920789
10 yn08-11 2008 JF920762 26 yn09-39 2009 JF920790
11 yn08-12 2008 JF920763 27 yn09-40 2009 JF920791
12 yn08-13 2008 JF920764 28 yn09-42 2009 JF920793
13 yn08-14 2008 JF920765 29 yn09-43 2009 JF920794
14 yn08-17 2008 JF920768 30 yn09-44 2009 JF920795
15 yn08-18 2008 JF920769 31 yn09-47 2009 JF920798
16 yn08-19 2008 JF920770 32 yn09-50 2009 JF920801
doi:10.1371/journal.pone.0033756.t002
Table 3. Analysis of nucleotide and amino acid identity of ORF5 among 32 PRRSV isolates and with represent PRRSV isolates LV,
VR-2332, RespPRRSV, Ch-1a, and highly pathogenic strain JX-A1.
Isolation
Years(No.) 2007 2008 2009 LV VR-2332 RespPRRS JX-A1 Ch-1a
2007(9) nt 86.9–99.8 86.2,99.8 86.2,99.8 61.7,62.9 87.6,99.0 87.2,99.3 88.4,98.8 91.5,94.9
aa 86.5–100.0 85.5,99.5 86.0,99.5 55.3,57.3 88.0,98.0 87.0,99.0 86.0,97.5 90.5,92.5
2008(13) nt - 86.2,99.8 86.2,99.8 61.7,62.9 86.9,99.0 87.2,99.3 88.1,99.3 91.2,95.4
aa - 85.5,99.5 86.0,100.0 54.3,57.8 87.5–98.0 86.5,99.0 85.5,99.0 90.0,93.5
2009(10) nt - - 94.5–99.8 61.9–62.2 86.9,89.4 87.1,89.1 93.7,99.2 92.9,95.2
aa - - 94.0,99.5 56.3,57.3 87.5,89.0 86.5,88.0 93.0,99.0 92.5,94.5
doi:10.1371/journal.pone.0033756.t003
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mutation (F39/L39RI39). To differentiate these isolates of
different subgenotypes, the unique or concurrent amino acid
mutations were observed. Three (L39RF39/I39, N58RS58/
Q58, K59RH59; and G9RC9, V94RA94, V185RA185) and
two (R13RQ13, R151RG151) unique mutations observed in
subgenotype 1 and subgenotype 2, respectively. Other represen-
tative concurrent amino acid mutations (S16RF16, C24RY24,
A29RV29, S66RT66, A92RG92, 101FR101Y, 102VR102Y,
T121RI121, A137RS137, I161RV161, R164RG164, I189RL189,
P200RL200) were also found in two subgenotypes.
Discussion
PRRS has become widespread since its initial outbreak in
mainland China at the end of 1995, the infection rate of Chinese
swine herds has risen to 90% [12]. An increasing number of field
PRRSV strains have been isolated from different regions of China.
However, all described PRRS viruses in China, including the HP-
PRRSV isolates almost simultaneously emerged both in China
and Vietnam in 2006, are of the North American genotype [13].
Recently, there was report that European genotype PRRSV
isolates were detected in swine herds both with and without
Figure 1. Phylogenetic relationship of PRRSVs. A neighbor-joining tree was constructed based on sequences of the ORF5 gene of PRRSV, with
bootstrap values calculated from 1,000 replicates. Subgroups are marked with different colors and the strains isolated in this study are indicated in
bold.
doi:10.1371/journal.pone.0033756.g001
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that they shared 87.0–91.5% and 58.0–58.2% identity with the
European and North American genotype prototypic strains LV
and VR-2332, respectively [12]. The coexistence of both
genotypes PRRSV in Chinese swine herds provides a suitable
environment for developing new viral biological characteristics.
Meanwhile, it complicates the prevention and control of PRRSV
in China.
ORF5 gene has been considered to be one of the least conserved
ORFs of PRRSV with respective sequence variability of up to
17%, which lead to a high degree of genetic polymorphism under
constant selective pressure even within the same genotype, and the
emergence of acute PRRS or highly variable PRRSV. The amino
acid substitutions of the GP5 protein between the PRRSV isolates
and representatives are mostly observed in the heterogenic signal
sequence and the two hyper variable regions [14,15]. Studies
based on ORF5 gene sequences of Chinese isolates have revealed
extensive genetic diversity, even in highly pathogenic PRRSV that
emerged in 2006 [11,16].
GP5 of PRRSV is associated with virus neutralization. Three B
cell epitopes, two T cell epitopes exists in the North American
genotype, and at least two of these epitopes are neutralization
epitopes. The PNE of both North American and European
PRRSV strains are located in the middle of the GP5 ectodomain,
which previously identified as S37H(F/L)QLIYN or S37H(F/
L)QLIYN LTLCELNG. The PNE plays an important role in viral
neutralization, and the residues H38L39/F39 in this domain are
considered to be the critical amino acids of the neutralizing
epitope [17,18]. In this study, analysis of PNE found that the key
antibody combined site (L/F)39 were mutation to I39 (isolates YN-
2, YN-3, YN08-23, YN08-24, YN08-29, YN08-31, YN09-47),
T39 (YN07-0) or P39 (YN-1), also amino acid mutations
C48RS48 (YN08-28) and N51RS51 (YN09-43) observed in
Yunnan isolates. These mutations likely lead to the failure of
immunization in Yunnan Province. Nevertheless, further studies
are necessary to provide additional evidence. In consideration of
that the immunogenicity and specificity of the linear neutralization
epitopes are not only determined by the amino acid sequence, but
also by conformational effects that are probably induced by amino
acid changes upstream or downstream of the epitope [19].
The epitope comprised of A27/V27LVN near the PNE is the
main antibody recognition site for epitope A. This epitope may
also act as a decoy, which elicit most of the antibodies against GP5
and delay the introduction of neutralizing antibodies for at the
least 3 weeks [18]. Among GP5 gene of 32 Yunnan isolates, this
decoy epitope was conserved in Subgenotype group 1, whereas
nine of ten strains in Subgenotype group 2 contained one amino
acid mutation at position 29 (VRA). The replacement of these
four amino acids considerably reduced the recognition of this
epitope.
The widely use of modified live-attenuated vaccines have
reduced the incidence and severity of PRRS outbreaks in many
countries. Nevertheless, live PRRSV vaccine virus exhibits an
untoward tendency to spread and reversion towards virulence .
The periodic identification of vaccine-like isolates poised the
challenge for detection and characterization of vaccine-like isolates
and field isolates of PRRSV [20–22]. Comparisons between the
vaccine virus and its parental virus showed that ORF5 codon
position 13, 151 and ORF6 codon position 15 play a key role in
denaturing VR2332 to RespPRRSV [23,24]. When VR-2332 was
attenuated to the RespPRRS/Repro vaccine strain, R13 and
R151 were altered to Q13 and G151, respectively [25]. Since
R13Q was included in the signal peptide, this mutation may also
have an effect on transfer of GP5. It has been reported that
R151G mutation has an effect on hydrophobic areas and reduces
the virulence of Czech strain V502 after 152 passages that resulted
in this mutation [26]. In this study, R13Q and R151G were
observed in nine of ten isolates in subgenotype 2, including a
middle virulent strain YN-1 that has been isolated and identified,
nevertheless there is no evidence to prove that the field isolates are
responsible for the reversion of the modified live PRRS vaccine.
In summary, nucleotide and amino acid sequence analysis of
GP5 of 32 PRRSV strains isolated in Yunnan from 2007 to 2009
revealed the prevalence of two subgenotypes of PRRSV in this
region. All strains isolated had divergence obviously from the first
Chinese isolate Ch-1a, and ten isolates (subgenotype 2) were
highly related to the vaccine strain. The occurrence of these
vaccine strain related isolates is presumably related to the
extensive use of the attenuated modified live PRRS vaccine since
live PRRSV vaccines can revert to virulence. In addition, our
study determined that a branch of subgenotype 1 is entirely made
up of Yunnan isolates, which raising the possibility that PRRSV
prevalence in this region has evolved into a separate branch.
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